University of Helsinki:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Helsinki - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9293
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Helsinki (UOH) is an educational service provider that offers research and graduate programs. The university operates through independent institutes and faculties for theology, law, medicine, arts, science, pharmacy, biological and environmental sciences, behavioral sciences, social sciences, Swedish school of social sciences, agriculture and forestry, and veterinary medicine. The university conducts various clinical research, genetic research, atmosphere and climate change research, social and scientific research, brain research, learning research, and research programs related to linguistic interaction, among others. It offers research in areas of digital world, ageing and health, globalisation and sustainable development. UOH is headquartered in Helsinki, Finland.

University of Helsinki – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Helsinki, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Helsinki, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Helsinki, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Helsinki, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Helsinki, Medical Devices Deals, 2012 to YTD 2018 10
University of Helsinki, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
University of Helsinki, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Mobidiag Raises Funds Through Venture Financing 12
Laurantis Pharma Raises US$7 Million In Venture Financing 14
Plexpress Raises US$1.4 Million In Initial Closing Of Venture Financing Round 15
Partnerships 16
Biocomputing Platforms Enters into Agreement with Helsinki University Central Hospital 16
Orion Enters into Co-Development Agreement with Helsinki University 17
Licensing Agreements 18
Herantis Pharma Enters into Licensing Agreement with University of Helsinki 18
Equity Offering 19
Nanoform Finland Spin Out from University of Helsinki 19
Valo Therapeutics Spin Out from University of Helsinki 20
University of Helsinki – Key Competitors 21
University of Helsinki – Key Employees 22
University of Helsinki – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 23
Recent Developments 24
Government and Public Interest 24
Nov 01, 2018: Orion Research Foundation grants million euros for research in 2019 24
Oct 16, 2018: Ad­vanced se­quen­cing tech­no­logy provides new in­sights into hu­man mi­to­chon­drial dis­eases 26
Oct 15, 2018: Mo­lecu­lar at­las of post­natal mouse heart de­vel­op­ment – a com­pre­hens­ive re­source for car­diac re­gen­er­at­ive medi­cine 27
Sep 05, 2018: Gestational diabetes may predispose to postpartum depression symptoms 28
Jun 11, 2018: Post-stroke de­liv­ery of neur­o­trophic factor MANF pro­motes func­tional re­cov­ery in rats 29
Apr 19, 2018: Novel dis­cov­er­ies on ag­gress­ive NK-cell leuk­emia pave the way for new treat­ments 30
Jan 29, 2018: Re­search­ers Identify a Novel Peri­odic Autoin­flam­mat­ory Syn­drome 31
Nov 15, 2017: New Study Suggests a Role for Gene Regulation in Schizophrenia 33
Oct 24, 2017: First HiLIFE Proof of Concept grants awar­ded 34
Product News 35
Nov 15, 2017: Nano­form shrinks drug particles 35
Sep 26, 2018: New can­cer vac­cine plat­form a po­ten­tial tool for tailored and ef­fic­a­cious tar­geted can­cer ther­apy 36
Other Significant Developments 37
Oct 17, 2018: Ver­sat­il­ity in a first-line drug for dia­betes – re­search­ers dis­cover an in­ter­est­ing mech­an­ism of ac­tion 37
Sep 11, 2018: Variation in cancer-causing KRAS mutations greater than thought 39
Jul 06, 2018: Re­search­ers de­ve­lop a new method for turn­ing skin cells into pluri­po­tent stem cells 40
Jun 11, 2018: Genome-editing tool could increase cancer risk 41
Apr 03, 2018: A new scientific publication suggests improved predictions of drug efficacy based on a new analytical method of cell-based experiments 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
University of Helsinki, Pharmaceuticals & Healthcare, Key Facts 2
University of Helsinki, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Helsinki, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Helsinki, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Helsinki, Deals By Therapy Area, 2012 to YTD 2018 9
University of Helsinki, Medical Devices Deals, 2012 to YTD 2018 10
University of Helsinki, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Mobidiag Raises Funds Through Venture Financing 12
Laurantis Pharma Raises US$7 Million In Venture Financing 14
Plexpress Raises US$1.4 Million In Initial Closing Of Venture Financing Round 15
Biocomputing Platforms Enters into Agreement with Helsinki University Central Hospital 16
Orion Enters into Co-Development Agreement with Helsinki University 17
Herantis Pharma Enters into Licensing Agreement with University of Helsinki 18
Nanoform Finland Spin Out from University of Helsinki 19
Valo Therapeutics Spin Out from University of Helsinki 20
University of Helsinki, Key Competitors 21
University of Helsinki, Key Employees 22
University of Helsinki, Subsidiaries 23
University of Helsinki, Joint Venture 23

List of Figures
University of Helsinki, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Helsinki, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Helsinki, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Helsinki, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Helsinki, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Helsinki, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
University of Helsinki, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Helsinki, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Helsinki, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[University of Helsinki:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sientra Inc (SIEN):企業の財務・戦略的SWOT分析
    Summary Sientra Inc (Sientra) is a medical device company that manufactures and markets plastic surgery implantable devices. The company’s products comprise breast implants, breast tissue expanders, silicone scar treatment and additional tissue expanders. It offers reconstructive surgery devices suc …
  • Ansaldo Energia SpA:電力:M&Aディール及び事業提携情報
    Summary Ansaldo Energia SpA (Ansaldo Energia), a subsidiary of CDP Equity SpA, is a power generation company and a supplier of power plant equipment and related services. It provides power plant equipment such as gas turbines, steam turbines, turbo generators, and hydro-generators used in fossil fue …
  • GW Pharmaceuticals Plc (GWP)-製薬・医療分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • French National Institute of Health and Medical Research:医療機器:M&Aディール及び事業提携情報
    Summary French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immu …
  • Kkr Financial Holdings Llc
    Kkr Financial Holdings Llc - Strategy, SWOT and Corporate Finance Report Summary Kkr Financial Holdings Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Hitachi Koki Co., Ltd.:企業の戦略的SWOT分析
    Hitachi Koki Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Theranostics Health Inc-製薬・医療分野:企業M&A・提携分析
    Summary Theranostics Health Inc (Theranostics), a subsidiary of Avant Diagnostics Inc is a healthcare service provider that offers protein based solutions. The company provides protein based discovery and translational research services. Its products include molecular navigation of targeted therapie …
  • Enyo Pharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Enyo Pharma SA (Enyo Pharma) is a biopharmaceutical company that develops molecules modulating host functions for the treatment of acute and chronic viral infections. The company provides technology which develops tools combining biological experimentation and computational development to id …
  • Argenx SE (ARGX):企業の財務・戦略的SWOT分析
    Summary Argenx SE (Argenx) is a human antibodies developer. The company offers autoimmunity and oncology products. Its wholly owned product candidates include ARGX-113, ARGX-110, ARGX-117 and ARGX-111. Argenx partnered product candidates are ARGX-109, ARGX-112, ARGX-115 AND ARGX-116. The company off …
  • P. H. Glatfelter Company (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Company (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • HUP-Zagreb d.d.:企業の戦略・SWOT・財務情報
    HUP-Zagreb d.d. - Strategy, SWOT and Corporate Finance Report Summary HUP-Zagreb d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Monster Beverage Corporation:企業の戦略・SWOT・財務情報
    Monster Beverage Corporation - Strategy, SWOT and Corporate Finance Report Summary Monster Beverage Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Goldcorp Inc:企業のM&A・事業提携・投資動向
    Goldcorp Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Goldcorp Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Idaho Power Co:企業の発電所・SWOT分析2018
    Idaho Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Zehnder Group AG (ZEHN):企業の財務・戦略的SWOT分析
    Zehnder Group AG (ZEHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ingersoll-Rand Plc (IR):電力:M&Aディール及び事業提携情報
    Summary Ingersoll-Rand Plc (Ingersoll-Rand) is an industrial manufacturer. It designs, manufactures, sells and services a portfolio of industrial and commercial products. The company’s offerings enhance the quality, energy efficiency and comfort of air in homes and buildings, transport and protect f …
  • Mirach Energy Ltd (AWO):石油・ガス:M&Aディール及び事業提携情報
    Summary Mirach Energy Ltd (Mirach Energy), formerly China Petrotech Holdings Ltd is a diversified company. The company operates through its business such as property and construction and oilfield services. Its oilfield services business offers enhanced oil recovery techniques and consultancy service …
  • Booking Holdings Inc:企業の戦略・SWOT・財務分析
    Booking Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Booking Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Portland General Electric Company:企業の戦略・SWOT・財務分析
    Portland General Electric Company - Strategy, SWOT and Corporate Finance Report Summary Portland General Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆